Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment

Apr 23, 2026 - 13:00
 0
Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment
Currency effects weighed on the Swiss drugmaker's first-quarter earnings